In September 2022 AIGEA Medical has been in Grenoble for the final event of ELISE program, attending the ECML22 conference, where Yan LeCun, Vice president and Chief AI scientist of Facebook, is giving a talk on the future of Machine Learning.
The ELISE partner discussed in the main conference auditorium their projects and AIGEA Medical focused on Artificial Intelligence NLP report generation for the screening analysis.
ELISE is part of the EU Horizon 2020 ICT-48 portfolio and originated from ELLIS, a network of artificial intelligence research hubs and associated Fellows. Based on the highest level research, it spreads its knowledge and methods in academia, industry and society.
AIGEA Medical and DeepMammo technology were selected for the program as excellence of Artificial Intelligence in medical and health technology.